Staar Surgical Co SEC filings STAA
Staar Surgical Co has 1,001 filings in SEC EDGAR's recent list, going back to Aug 19, 2013. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Jan 2, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Oct 2, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on January 2.
| Form | Description | Filed | Period |
|---|---|---|---|
| DFAN14A | Definitive additional materials | Dec 19, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 17, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 16, 2025 | — |
| PX14A6G | Notice of exempt solicitation | Dec 16, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 12, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 11, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 11, 2025 | — |
| PX14A6G | Notice of exempt solicitation | Dec 11, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 10, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 9, 2025 | — |
| DFAN14A | Filing | Dec 9, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 8, 2025 | — |
| DFAN14A | Definitive additional materials | Dec 2, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 19, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 12, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 10, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 6, 2025 | — |
| PX14A6G | Filing | Nov 6, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 4, 2025 | — |
| DFAN14A | Filing | Nov 4, 2025 | — |
| DFAN14A | Definitive additional materials | Nov 3, 2025 | — |
| PX14A6G | Filing | Nov 3, 2025 | — |
| PX14A6G | Filing | Oct 27, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 24, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 22, 2025 | — |
| PX14A6G | Filing | Oct 21, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 20, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 17, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 15, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 14, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 10, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 9, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 8, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 7, 2025 | — |
| PX14A6G | Filing | Oct 7, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 6, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 3, 2025 | — |
| DFAN14A | Definitive additional materials | Oct 2, 2025 | — |
| DFAN14A | Definitive additional materials | Sep 29, 2025 | — |
| DFAN14A | Definitive additional materials | Sep 26, 2025 | — |
| DFAN14A | Definitive additional materials | Sep 24, 2025 | — |
| DEFC14A | Definitive proxy statement | Sep 24, 2025 | — |
| PX14A6G | Filing | Sep 22, 2025 | — |
| DFAN14A | Soliciting material under 240.14a-12 | Sep 18, 2025 | — |
| PREC14A | Preliminary proxy statement | Sep 15, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| CORRESP | Letter to the SEC | Feb 28, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2024 | — |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2023 | — |
| EFFECT | Filing | Feb 22, 2021 | — |
| CORRESP | Letter to the SEC | Feb 18, 2021 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| UPLOAD | Letter from the SEC | May 14, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2018 | — |
| CORRESP | Letter to the SEC | Dec 11, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2017 | — |
| CORRESP | Letter to the SEC | Nov 17, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2017 | — |
| EFFECT | Filing | Jun 9, 2017 | — |
| CORRESP | Letter to the SEC | Jun 2, 2017 | — |
| UPLOAD | Letter from the SEC | May 31, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2014 | — |
| CT ORDER | Filing | Aug 25, 2014 | — |
| CORRESP | Letter to the SEC | Aug 21, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2014 | — |
| EFFECT | Filing | May 12, 2014 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- STAA (Nasdaq)
- Fiscal year ends
- January 2
- Incorporated in
- DE
- Headquarters
- Monrovia, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 718937
- Former names
- STAAR SURGICAL COMPANY (until Aug 17, 2004)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.